Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Rituximab in Turkish neuromyelitis optica patients with limited response to other immunosuppressants.
Tracking CNS and systemic sources of oxidative stress during the course of chronic neuroinflammation.
Osmotic demyelination syndrome complicating diabetes with anti-glutamic acid decarboxylase antibodies and Graves' disease: A case report.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Polymorphisms of Immunoglobulin G Fc Receptors in Pediatric Guillain-Barré Syndrome.
The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada.
Nerve pathologic features differentiate POEMS syndrome from CIDP.
Pediatric idiopathic transverse myelitis presenting as an anterior cord syndrome: A case report.
Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
Healthcare Costs Associated with Patients Diagnosed with Relapsing Remitting Multiple Sclerosis.
Human myelin proteome and comparative analysis with mouse myelin.
Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study.
Schwann cells-axon interaction in myelination.
[Current and historical concept of neuromyelitis optica].
Modeling The Natural History of Secondary-Progressive Multiple Sclerosis: A New Modeling Approach Using Discrete Event Simulation.
Alterations in hippocampal myelin and oligodendrocyte precursor cells during epileptogenesis.
Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects.
Short-Term Effect of BalanceWear Therapy on Mobility in Older Adults With Mobility Limitations.
Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms).
Good cardiac safety in patients with relapsing remitting multiple sclerosis upon first fingolimod dose.
Cavernous angioma: a clinical study of 35 cases with review of the literature.
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
A novel internet-based method of capturing outcomes in multiple sclerosis.
Correction: The Extracellular Domain of Myelin Oligodendrocyte Glycoprotein Elicits Atypical Experimental Autoimmune Encephalomyelitis in Rat and Macaque Species.
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.
Pages
« first
‹ previous
…
680
681
682
683
684
685
686
687
688
…
next ›
last »